Evidence map›Paper›PMID 31202737›Full record

ArticleApplied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine2020

Corrigendum to "Automated cassette-based production of high specific activity [

Mengshi Li, Xiuli Zhang, Thomas P Quinn, Dongyoul Lee, Dijie Liu, Falk Kunkel, Brian E Zimmerman, Daniel McAlister, Keith Olewein, Yusuf Menda and 4 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Mengshi LiInterdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA, USA.
Xiuli ZhangDepartment of Biochemistry, University of Missouri, Columbia, MO, USA.
Thomas P QuinnDepartment of Biochemistry, University of Missouri, Columbia, MO, USA.
Dongyoul LeeInterdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA, USA.
Dijie LiuStead Family Department of Pediatrics, University of Iowa, Iowa City, IA, USA.
Falk KunkelEckert & Ziegler Radiopharma GmbH, Berlin, Germany.
Brian E ZimmermanNational Institute of Standards and Technology, Gaithersburg, MD, USA.
Daniel McAlisterEichrom Technologies, LLC, Lisle, IL, USA.
Keith OleweinLantheus Medical Imaging, North Billerica, MA, USA.
Yusuf MendaDepartment of Radiology, The University of Iowa, Iowa City, IA, USA.
Saed MirzadehOak Ridge National Laboratory, The US Department of Energy, Oak Ridge TN, USA.
Roy CoppingOak Ridge National Laboratory, The US Department of Energy, Oak Ridge TN, USA.
Frances L JohnsonViewpoint Molecular Targeting, LLC, Coralville, IA, USA; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Michael K SchultzInterdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA, USA; Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA, USA; Department of Radiology, The University of Iowa, Iowa City, IA, USA; Viewpoint Molecular Targeting, LLC, Coralville, IA, USA; Department of Radiation Oncology (Free Radical and Radiation Biology Program), Carver College of Medicine, University of Iowa, Iowa City, IA, USA; Department of Chemistry, University of Iowa, Iowa City, IA, USA. Electronic address: michael-schultz@uiowa.edu.
University of Iowa · USOak Ridge National Laboratory · USUniversity of Missouri · USViewpoint Molecular Targeting (United States) · USLantheus Medical Imaging (United States) · USNational Institute of Standards and Technology · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Image-guided Diagnosis and Therapy of Neuroendocrine TumorsR01CA167632 · NCI · UNIVERSITY OF IOWA · PI MENDA, YUSUF, O'DORISIO, M. SUE · 2012 to 2016
$2.6M
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine TumorsR01CA243014 · NCI · UNIVERSITY OF IOWA · PI MENDA, YUSUF · 2019 to 2024
$2.5M
NCI NIH HHS R01 CA167632NCI NIH HHS R01 CA243014
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31202737
OpenAlexW2951540227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.